- Medtronic Cryoablation Superior to Drug Therapy for Symptomatic Paroxysmal Atrial Fibrillation
- Medtronic Reports First Quarter Financial Results
- Medtronic Board Appoints Kevin Lofton as a New Director
- Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2021
- Medtronic Evolut TAVR System Receives Updated U.S. Labeling Revising Precaution for Treatment of Low-Risk Patients with Bicuspid Aortic Stenosis
- Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System
- Study Published in The New England Journal of Medicine Demonstrates Patients Experience Fewer Disruptions to Dialysis Therapy When Treated with Medtronic Drug-Coated Balloon
- Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2021
- Medtronic to Acquire Smart Insulin Pen Company Companion Medical
- Medtronic Announces Comprehensive U.S. Launch of New InterStim™ Micro Neurostimulator
More ▼
Key statistics
On Tuesday, Medtronic PLC (0Y6X:LSE) closed at 125.91, -0.45% below its 52-week high of 126.48, set on Apr 16, 2021.
52-week range
Markit short selling activity
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | 18.41k |
---|---|
Shares outstanding | 1.35bn |
Free float | 1.35bn |
P/E (TTM) | 59.69 |
Market cap | 170.03bn USD |
EPS (TTM) | 2.11 USD |
Annual div (ADY) | 2.32 USD |
---|---|
Annual div yield (ADY) | 1.85% |
Div ex-date | Mar 25 2021 |
Div pay-date | Apr 16 2021 |
Data delayed at least 20 minutes, as of Apr 20 2021 14:30 BST.
More ▼